Company intelligence / Profile preview

Redberry

Illkirch-Graffenstaden, Grand Est, Franceredberry.cc ↗

Ownership: Private
Employees: ~18
Development stage: Commercial

Overview

Redberry has developed a patented solid-phase cytometry platform for rapid and precise microbial detection. The system enables direct counting of total viable flora (excluding spores), bioburden assessment within 4 hours, enumeration of total aerobic flora, and sterility testing within 4 days. It is designed for use in pharmaceutical manufacturing, water quality control, and personal care product safety. The technology provides results much faster than traditional culture-based methods and is compliant with regulatory standards such as 21 CFR part 11[1][5].

Therapeutic areas: Infectious Diseases
Modalities: DeviceDiagnostic platform (solid-phase cytometry)
Industry: Molecular Diagnostics

Partnerships

Not specified; may include collaborations with pharma manufacturers or quality control labs.

Beyond the preview

Go deeper on Redberry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redberry.

Explore the full profile